Spots Global Cancer Trial Database for Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy
Official Title: A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy
Study ID: NCT02011659
Interventions
Study Description
Brief Summary: To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of gynecologic patients undergoing laparoscopic surgery after scheduled administration of intravenous Ramosetron during hospital stays. * Randomized controlled arm : Placebo versus Ramosetron injection * Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs after surgery
Detailed Description: Surgical outcomes including operative time, blood loss, Hb change, postoperative pain, nausea/vomiting scale, times of rescue therapy, and complications
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
National Health Insurance Service Ilsan Hospital, Goyang-si, , Korea, Republic of
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
